These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36672717)

  • 1. Age-Related Decline in Gangliosides GM1 and GD1a in Non-CNS Tissues of Normal Mice: Implications for Peripheral Symptoms of Parkinson's Disease.
    Chowdhury S; Wu G; Lu ZH; Kumar R; Ledeen R
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gangliosides, α-Synuclein, and Parkinson's Disease.
    Ledeen RW; Wu G
    Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson's Disease?
    Alselehdar SK; Chakraborty M; Chowdhury S; Alcalay RN; Surface M; Ledeen R
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic deficiency of GM1 ganglioside in Parkinson's disease tissues and its relation to the disease etiology.
    Ledeen R; Chowdhury S; Lu ZH; Chakraborty M; Wu G
    Glycoconj J; 2022 Feb; 39(1):75-82. PubMed ID: 34973149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model.
    Hadaczek P; Wu G; Sharma N; Ciesielska A; Bankiewicz K; Davidow AL; Lu ZH; Forsayeth J; Ledeen RW
    Exp Neurol; 2015 Jan; 263():177-89. PubMed ID: 25448159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Key Role of GM1 Ganglioside in Parkinson's Disease.
    Chowdhury S; Ledeen R
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic GM1 improves motor and memory dysfunctions in mice with monoallelic or biallelic disruption of GM3 synthase.
    Chowdhury S; Kumar R; Zepeda E; DeFrees S; Ledeen R
    FEBS Open Bio; 2023 Sep; 13(9):1651-1657. PubMed ID: 37401916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson's disease; successful treatment with synthetic GM1 ganglioside.
    Wu G; Lu ZH; Seo JH; Alselehdar SK; DeFrees S; Ledeen RW
    Exp Neurol; 2020 Jul; 329():113284. PubMed ID: 32165255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse.
    Itokazu Y; Fuchigami T; Morgan JC; Yu RK
    Mol Ther; 2021 Oct; 29(10):3059-3071. PubMed ID: 34111562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans.
    Wu G; Lu ZH; Kulkarni N; Ledeen RW
    J Neurosci Res; 2012 Oct; 90(10):1997-2008. PubMed ID: 22714832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangliosides in Neurodegenerative Diseases.
    Ledeen R; Chowdhury S
    Adv Neurobiol; 2023; 29():391-418. PubMed ID: 36255682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory role of GM1 and other gangliosides on microglia.
    Galleguillos D; Wang Q; Steinberg N; Zaidi A; Shrivastava G; Dhami K; Daskhan GC; Schmidt EN; Dworsky-Fried Z; Giuliani F; Churchward M; Power C; Todd K; Taylor A; Macauley MS; Sipione S
    J Neuroinflammation; 2022 Jan; 19(1):9. PubMed ID: 34991625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related changes in GM1, GD1a, GT1b components of gangliosides in Wistar albino rats.
    Aydin M; Cengiz S; Agaçhan B; Yilmaz H; Isbir T
    Cell Biochem Funct; 2000 Mar; 18(1):41-5. PubMed ID: 10686582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.
    Schneider JS; Seyfried TN; Choi HS; Kidd SK
    PLoS One; 2015; 10(12):e0143351. PubMed ID: 26629687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of major gangliosides in the PNS: implications for immune neuropathies.
    Gong Y; Tagawa Y; Lunn MP; Laroy W; Heffer-Lauc M; Li CY; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2002 Nov; 125(Pt 11):2491-506. PubMed ID: 12390975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S
    Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between depletion of brain GM1 ganglioside and Parkinson's disease.
    Sonnino S
    FEBS Open Bio; 2023 Sep; 13(9):1548-1557. PubMed ID: 36638010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
    Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
    Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson's disease.
    Schneider JS
    Glycoconj J; 2022 Feb; 39(1):13-26. PubMed ID: 34037912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gangliosides in nervous system development, regeneration, and pathologies.
    Vasques JF; de Jesus Gonçalves RG; da Silva-Junior AJ; Martins RS; Gubert F; Mendez-Otero R
    Neural Regen Res; 2023 Jan; 18(1):81-86. PubMed ID: 35799513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.